|
Product Name |
Abaloparatide peptide |
|
Other Name |
Abaloparatide;Abaloparatide (BA058) |
|
Appearance |
White to off-white powder |
|
Sequence |
H-Ala-Val-Ser-Glu-His-Gln-Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-Ile-Gln-Asp-Leu-Arg-Arg-Arg-Glu-Leu-Leu-Glu-Lys-Leu-Leu-N-Me-Ala-Lys-Leu-His-Thr-Ala-NH2 |
|
Assay |
99% by HPLC |
|
Molecular Formula |
C174H300N56O49 |
|
CAS Number |
247062-33-5 |
|
Solubility |
H2O/DMSO |
|
Storage |
Cool dry place( Store at -20°C, away from the light) |
Products Description
What is Abaloparatide peptide?
Abaloparatide is a synthetic peptide analog, a linear peptide composed of 34 amino acids. It mimics a specific portion of the parathyroid hormone-related protein found in the human body. It is a potent anabolic agent (i.e., "bone-building drug") used to treat osteoporosis.
Xi 'an Tongze can provide other peptide products, the catalog is as follows, welcome to consult!
|
Product Name |
CAS No. |
|
Goralatide |
127103-11-1/120081-14-3 |
|
ARA-290(Cibinetide) |
1208243-50-8 |
|
N-acetyl Semax Amidate |
2920938-90-3 |
|
N-AC-selank-amidate |
N/A |
|
Aviptadil Acetate |
40077-57-4 |
|
GLP-1(1-37) |
87805-34-3 |
|
GIP (huMan) |
100040-31-1 |
|
N-Acetyl-Semax |
N/A |
|
N-Acetyl Selank |
N/A |
|
S-Phenylacetyl Larazotide |
N/A |
|
Dermorphin |
77614-16-5 |
|
PEG-MGF |
N/A |
|
Met-enkephalin |
58569-55-4 |
|
Pramlintide Acetate |
196078-30-5 |
|
Dalargin |
81733-79-1 |
|
Abaloparatide |
247062-33-5 |
|
N-Acetyl Larazotide |
N/A |
|
Humanin |
330936-69-1 |
|
Adamax |
N/A |
COA of Abaloparatide peptide
|
Product Name |
Abaloparatide |
CAS Number |
247062-33-5 |
|
Manufacture Date |
2025/11/01 |
Expiration Date |
2027/10/31 |
|
Batch Number |
HSW251101 |
Batch Quantity |
1kg |
|
Sequence |
H-Ala-Val-Ser-Glu-His-Gln-Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-Ile-Gln-Asp-Leu-Arg-Arg-Arg-Glu-Leu-Leu-Glu-Lys-Leu-Leu-N-Me-Ala-Lys-Leu-His-Thr-Ala-NH2 |
||
|
Item |
Specification |
Results |
|
Appearance |
White or almost white fluffy powder |
Conform |
|
Mass Spectrum |
639.79 ±1 |
Conform |
|
Purity (By HPLC) |
≥98.0% |
99.50% |
|
Water Content (Karl Fischer) |
≤8.0% |
6.90% |
|
Acetic Acid(By HPLC) |
≤15.0% |
6.80% |
|
Solubility |
Soluble in water |
Conform |
|
Organic Solvent Residue |
Dichloromethane≤0.060% |
<0.006% |
|
Acetonitrile≤0.041% |
<0.041% |
|
|
N.N-Dimethylfomamide≤0.088% |
<0.088% |
|
|
Related Substance
|
Total lmpurities≤ 2.0% |
0.5% |
|
Largest Single Impurity≤1.0% |
0.2% |
|
|
Conclusion |
This batch complies with enterprise standard. |
|
|
Packing |
Pack in paper-drums and two plastic-bags inside. |
|
|
Storage |
Keep in dark and cool dry place ,2 to 8°C |
|
|
Shelf life |
2 Years When Stored properly |
|
Benefits of Abaloparatide peptide
1. Significant Reduction in Fracture Risk
New vertebral fracture risk decreased by 86%, and non-vertebral fracture risk decreased by 43%. This represents one of the largest reductions in vertebral fracture risk among current osteoporosis medications.
2. Bone Mineral Density Improvement
After 18 months of treatment, lumbar spine bone mineral density increased by an average of >12%, and hip bone mineral density increased by approximately 3-6%. The rate of improvement is rapid and substantial.
3. Rapid Onset of Action
Reduced fracture risk becomes observable within 3-6 months, while bone turnover markers (e.g., PINP) show significant elevation within one month.
4. Treatment Option Following Failure
For patients with inadequate response, intolerance, or recurrent fractures on oral bisphosphonates, abaloparatide offers a potent advanced treatment option.
|
Respect |
Advantage |
Disadvantages/Precautions |
|
Curative effect |
It exhibits potent osteogenic effects, significantly enhancing bone density and reducing fracture risk. |
The therapeutic effect has a limited duration (up to 2 years). |
|
Safety |
The risk of causing hypercalcemia is relatively low. |
Black box warning (osteosarcoma); contraindications must be ruled out. |
|
Convenience |
Pre-filled injection pens are relatively easy to use. |
Daily injections require high patient compliance; injection site reactions may occur. |
|
Economy |
- |
Highly priced, typically requiring prior authorization from health insurance, with potentially significant out-of-pocket costs for patients. |
|
Follow-up treatment |
- |
Following treatment, antiresorptive therapy must be initiated immediately (sequential therapy), otherwise bone mass will rapidly decline. |
Special Populations and Safety Consideration
1. Patients with Renal Impairment
No dose adjustment is required for patients with mild to moderate renal impairment, and the low risk of hypercalcemia is particularly advantageous in this group. Data for patients with severe renal impairment or on dialysis are limited; use requires extreme caution.
2. Elderly Patients (>75 years old)
Therapeutic efficacy remains substantial, but the risk of falls (due to dizziness as a side effect) warrants careful assessment. The benefits of fracture prevention must be weighed against the increased risk of falls.
Packing & Shipping
Customer Feedback
OEM/ODM Service
FAQ
Q: Can we offer Related products of Abaloparatide peptide?
A: Yes, We can provide all products related to Abaloparatide peptide, welcome to consult!
Q: How do you treat quality complaint ?
A:First of all, our quality control will reduce the quality problem to near zero. If there is a quality problem caused by us, we will send you free goods for replacement or refund your loss.
Q:What is Moq of Abaloparatide peptide?
A: Moq is 1gram.
Q:Is there a discount?
A:Of course, welcome to contact us. Price would be different based on different quantity. For bulk quantity, we will have discount for you.At the same time, we have a detailed list of discounted products and products with large inventory every quarter.
Q:Whether customized services can be provided
A:We offer ODM/OEM services and can manufacture according to specified formulations. We have our own designers who can design and customize private brands, packaging. Our customized service from the production of raw materials, design of brands/packaging, to the production of customized packaging, and then to packaging, mailing packages, one-stop production line, welcome to visit.
CONTACT PAGE
1.Inquiry methods：
Email:alice@xaheshun.com
Whatspp:+8618509260106
Online instant messaging
2.Contact Information：
Name：Alice
Telephone :+8618509260106
Email:alice@xaheshun.com
Hot Tags: abaloparatide peptide, China abaloparatide peptide manufacturers, suppliers, factory, Fenbendazole for Worm Prevention in Animals, Sulforaphane for Inflammation Reduction, Dihydroberberine for Blood Sugar Control, Ivermectin Antiparasitic Powder, Ivermectin Powder for Livestock, Berberine for Antioxidant Protection
